Peter Lichtlen
2013
In 2013, Peter Lichtlen earned a total compensation of $557.8K as Chief Medical Officer at Sucampo Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $66,599 |
|---|---|
| Salary | $242,760 |
| Other | $248,436 |
| Total | $557,796 |
Lichtlen received $248.4K in other compensation, accounting for 45% of the total pay in 2013.
Lichtlen also received $66.6K in non-equity incentive plan and $242.8K in salary.
Rankings
In 2013, Peter Lichtlen's compensation ranked 8,959th out of 12,286 executives tracked by ExecPay. In other words, Lichtlen earned more than 27.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,959 out of 12,286 | 27th |
Division Manufacturing | 3,266 out of 4,612 | 29th |
Major group Chemicals And Allied Products | 1,041 out of 1,462 | 29th |
Industry group Drugs | 796 out of 1,156 | 31st |
Industry Pharmaceutical Preparations | 629 out of 890 | 29th |
Source: SEC filing on April 18, 2016.